Showing 145 - 156 of 1862
China's retreat from lending to developing countries has come at precisely the wrong time for the global economy.
Despite regulatory obstacles, big pharma is so confident in China’s R&D they’re purchasing the rights to medicines that don’t yet exist.
The economist talks about the world economy’s break down into two blocs, and whether the U.S. or China hold the advantage.
On the eve of the 25th anniversary of the Hainan spy plane crisis, The Wire China talks with participants and reviews first-person accounts of the...
Also, OpenClaw grips China.
The EV giant is hoping AI-driven systems for cars and robots will help drive profits.
A backlash from so-called ‘lobster victims’ following a frenzy to download the AI agent has prompted Chinese regulators into action.
A Canadian lawmaker’s comments on Xinjiang has put a spotlight on the country’s shaky commitment to banning forced labor imports.
The longtime diplomat says the U.S. president’s approach to China during his second term could offer Beijing opportunities.
From energy and data centers to chips and applications, how China measures up against the U.S.
The Wire takes stock of the U.S.-China trade picture and the effort to shift global manufacturing back to America a year on from Liberation Day.
Beijing’s attempt to punish Japan over Taiwan is a major strategic blunder that is likely to backfire.